Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
28.84
+0.06 (0.21%)
At close: Oct 29, 2026, 4:00 PM EDT
28.20
-0.64 (-2.22%)
After-hours: Oct 29, 2026, 7:56 PM EDT

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $490.00K in the quarter ending June 30, 2026, a decrease of -94.21%. This brings the company's total for the last twelve months to $156.04M, up 158.88% year-over-year. In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth. That makes Beam Therapeutics the 19,297th largest company in the world by revenue and 3,027th in the United States.

Revenue (ttm)
$156.04M
Revenue Growth
+158.88%
P/S Ratio
18.47
Revenue / Employee
$288,954
Employees
540
Market Cap
2.88B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.